17/08/2012 13:37:00

India GlaxoSmithKline Pharma to Shut Factory in Western India

By Rumman Ahmed

BANGALORE--GlaxoSmithKline Pharmaceuticals Ltd. (500660.BY) Friday said operations at its factory at Thane in western India have ceased after all workers there accepted a voluntary retirement scheme offered by the company.

The relevant applications for closure of the factory are being filed, the Indian unit of GlaxoSmithKline PLC (GSK.LN) informed stock exchanges. The company didn't give any other details.

GlaxoSmithKline Pharmaceuticals has two manufacturing units in India, located at Thane and Nashik, also in western India. It also has a clinical development centre in Bangalore.

The Thane factory manufactured bulk drugs and active pharmaceutical ingredients, information available of the company's website showed. It makes finished forms of drugs at Nashik.

Write to Rumman Ahmed at rumman.ahmed@dowjones.com

Subscribe to WSJ: https://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

August 17, 2012 08:37 ET (12:37 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Related content
04 Mar - 
New Research: Key Drivers of Growth for GlaxoSmithKline..
04 Dec - 
Bragar Eagel & Squire, P.C. is Investigating the Board ..
03 Dec - 
GSK reaches agreement to acquire TESARO, an oncology fo..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
With $3M Dividend in 2019, Nonprofit Insurer's Dividends Paid to Members Top $44.1M
2
Extendicare Announces Nomination of Two New Directors and Agreement with Sandpiper Group
3
Hua Medicine Initiates First Combination Study of Dorzagliatin with SGLT-2 in the United States
4
PDF Solutions® Announces First Fiscal Quarter Financial Results Release Date
5
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Nokia Corporation (NOK) and Encourages NOK Investors to Contact the Firm

Related stock quotes

Glaxosmithkline PLC ORD .. 1,557.20 2.2% Stock price increasing
GlaxoSmithKline PLC 40.22 1.4% Stock price increasing
GlaxoSmithKline Ord Shs 1,557.20 2.2% Stock price increasing

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 April 2019 23:34:46
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190410.2 - EUROWEB7 - 2019-04-24 00:34:46 - 2019-04-23 23:34:46 - 1000 - Website: OKAY